Li Y - Search Results

1

Elevated serum IL-35 levels in rheumatoid arthritis are associated with disease activity.

Li Y, Yao L, Liu S, Wu J, Xia L, Shen H, Lu J. Li Y, et al. J Investig Med. 2019 Mar;67(3):707-710. doi: 10.1136/jim-2018-000814. Epub 2019 Jan 18. J Investig Med. 2019. PMID: 30659089

2

Interleukin-35 attenuates collagen-induced arthritis through suppression of vascular endothelial growth factor and its receptors.

Wu S, Li Y, Li Y, Yao L, Lin T, Jiang S, Shen H, Xia L, Lu J. Wu S, et al. Among authors: li y. Int Immunopharmacol. 2016 May;34:71-77. doi: 10.1016/j.intimp.2016.02.018. Epub 2016 Feb 26. Int Immunopharmacol. 2016. PMID: 26922678

3

Interleukin-35 (IL-35) inhibits proliferation and promotes apoptosis of fibroblast-like synoviocytes isolated from mice with collagen-induced arthritis.

Li Y, Wu S, Li Y, Jiang S, Lin T, Xia L, Shen H, Lu J. Li Y, et al. Mol Biol Rep. 2016 Sep;43(9):947-56. doi: 10.1007/s11033-016-4034-7. Epub 2016 Jul 5. Mol Biol Rep. 2016. PMID: 27379996

4

IL-35 Inhibits Angiogenesis through VEGF/Ang2/Tie2 Pathway in Rheumatoid Arthritis.

Jiang S, Li Y, Lin T, Yuan L, Li Y, Wu S, Xia L, Shen H, Lu J. Jiang S, et al. Among authors: li y. Cell Physiol Biochem. 2016;40(5):1105-1116. doi: 10.1159/000453165. Epub 2016 Dec 14. Cell Physiol Biochem. 2016. PMID: 27960151 Free article.

5

Interleukin-35 inhibits angiogenesis through STAT1 signalling in rheumatoid synoviocytes.

Wu S, Li Y, Yao L, Li Y, Jiang S, Gu W, Shen H, Xia L, Lu J. Wu S, et al. Among authors: li y. Clin Exp Rheumatol. 2018 Mar-Apr;36(2):223-227. Epub 2017 Aug 28. Clin Exp Rheumatol. 2018. PMID: 28850026

6

Elevation of Serum IL-35 in Patients with Primary Sjögren's Syndrome.

Han M, Li Y, Liu S, Jiang S, Yuan L, Xia L, Shen H, Lu J. Han M, et al. Among authors: li y. J Interferon Cytokine Res. 2018 Oct;38(10):452-456. doi: 10.1089/jir.2018.0059. Epub 2018 Sep 25. J Interferon Cytokine Res. 2018. PMID: 30256702

7

IL-35 prevent bone loss through promotion of bone formation and angiogenesis in rheumatoid arthritis.

Liu S, Li Y, Xia L, Shen H, Lu J. Liu S, et al. Among authors: li y. Clin Exp Rheumatol. 2019 Sep-Oct;37(5):820-825. Epub 2019 Feb 11. Clin Exp Rheumatol. 2019. PMID: 30767867 Free article.

8

Interleukin-35: A Serological Biomarker for Patients with Polymyositis/Dermatomyositis.

Jiang Q, Li Y, Xia L, Shen H, Lu J. Jiang Q, et al. Among authors: li y. J Interferon Cytokine Res. 2019 Nov;39(11):720-725. doi: 10.1089/jir.2019.0063. Epub 2019 Jul 8. J Interferon Cytokine Res. 2019. PMID: 31274382

9

Interleukin-35 stimulates tumor necrosis factor-α activated osteoblasts differentiation through Wnt/β-catenin signaling pathway in rheumatoid arthritis.

Li Y, Yuan L, Jiang S, Liu S, Xia L, Shen H, Lu J. Li Y, et al. Int Immunopharmacol. 2019 Oct;75:105810. doi: 10.1016/j.intimp.2019.105810. Epub 2019 Aug 9. Int Immunopharmacol. 2019. PMID: 31404890

10

Correlation between Serum IL-35 Levels and Bone Loss in Postmenopausal Women with Rheumatoid Arthritis.

Li Y, Yao L, Liu S, JishengWu, Xia L, Shen H, Lu J. Li Y, et al. Mediators Inflamm. 2019 Aug 26;2019:9139145. doi: 10.1155/2019/9139145. eCollection 2019. Mediators Inflamm. 2019. PMID: 31534439 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238,916 results

Search Page

Filters